Barristers

The director of collapsed Shangri-La Construction is personally liable for the $3.2 million in costs of rectification work on external cladding at an apartment complex in southeast Melbourne, a judge has found.

Mining equipment supplier Southern Cross Industrial has lost its suit alleging an industrial lighting manufacturer infringed its patent for a portable light tower, with a judge finding the patent invalid.

A judge has declined to order US-based animal genomics company Scidera to file a position statement in its bovine gene patent infringement suit and said she was “running out of patience” after unsuccessful strike-out and summary dismissal applications by the defendants.

A company linked to the Victorian Liberal Party that provided a $1.5 million advance to former party leader John Pesutto says a case launched to block the loan should be thrown out.

ASIC has called for a court to strike out negligence and public misfeasance claims in a suit by billionaire Clive Palmer alleging the regulator and its chief investigator were "improperly influenced” by corporate rivals.

BHP must compensate coal mine workers who were rostered to work at a Queensland mine on Christmas and Boxing Day without a reasonable right of refusal.

Russia has lost its High Court challenge to the federal government’s decision to terminate its lease on a site where it intended to build a new embassy in Canberra, but the court found the Commonwealth must pay the country reasonable compensation. 

After selling his $26 million Rose Bay mansion to AsheMorgan principal Michael Rothner in 2023, options trader David Waterhouse has levied allegations of “deliberate bad faith conduct”, on the first day of trial in a case over the mysterious removal of trees on a neighbouring property.

A judge has ordered a flat contingency fee at a rate below the maximum sought by the firm running a class action against Mineral Resources, agreeing with a colleague that recent shareholder class action losses don't justify a higher percentage.

Cosette plans to appeal a ruling that rejected its bid to terminate an agreement to merge with Mayne Pharma, as the US drug company also refuses to agree to conditions needed to win Foreign Investment Review Board approval for the tie-up.